Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections.

Lin, Dan-Yu; Abi Fadel, Francois; Huang, Shuaiqi; Milinovich, Alex T; Sacha, Gretchen L; Bartley, Patricia; Duggal, Abhijit; Wang, Xiaofeng

Lin, Dan-Yu; Abi Fadel, Francois; Huang, Shuaiqi; Milinovich, Alex T; Sacha, Gretchen L; Bartley, Patricia; Duggal, Abhijit; Wang, Xiaofeng.

Afiliação

Lin DY; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill.
Abi Fadel F; Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, Ohio.
Huang S; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Milinovich AT; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Sacha GL; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio.
Bartley P; Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio.
Duggal A; Department of Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio.
Wang X; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.

JAMA Netw Open ; 6(9): e2335077, 2023 09 05.

Article em En | MEDLINE | ID: mdl-37733342

Assuntos

COVID-19; Humanos; Masculino; Feminino; COVID-19/epidemiologia; Teste para COVID-19; Vacinas contra COVID-19; Estudos de Coortes; Ritonavir/uso terapêutico; SARS-CoV-2; Tratamento Farmacológico da COVID-19

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google